Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.56 |
| ▸ | HPGD | P15428 | 7/20 | 0.56 |
| ▸ | RAB9A | P51151 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | ELANE | P08246 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1699093 | 0.93 | KMT2A (0.64) | ALDH1A1HPGDRAB9ASMN1; SMN2HTT | |
| SCHEMBL9481728 | 0.87 | NPC1 (0.47) | ALDH1A1HPGDRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL13875297 | 0.86 | ERCC5 (0.61) | ALDH1A1HPGDRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL10886178 | 0.80 | KMT2A (0.57) | ALDH1A1HPGDRAB9ASMN1; SMN2HTT | |
| SCHEMBL28485298 | 0.79 | NPC1 (0.60) | ALDH1A1HPGDRAB9ASMN1; SMN2HTT | |
| SCHEMBL19806689 | 0.78 | ERCC5 (0.56) | ALDH1A1RAB9ASMN1; SMN2HTTMEN1 | |
| SCHEMBL16553571 | 0.78 | GSK3B (0.53) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL11947795 | 0.78 | MAPT (0.59) | ALDH1A1HPGDRAB9ASMN1; SMN2HTT | |
| SCHEMBL527362 | 0.78 | PLOD2 (0.55) | ALDH1A1HPGDRAB9ASMN1; SMN2HTT | |
| SCHEMBL11689197 | 0.76 | KMT2A (0.57) | ALDH1A1HPGDRAB9ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2203496-B1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2018-04-11 | — | — | EP | disclosed |
| EP-2203496-B1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2018-04-11 | — | — | EP | disclosed |
| US-8318830-B2 | Photolatent catalysts based on organometallic compounds | BASF SE (DE) | 2012-11-27 | — | — | US | disclosed |
| US-8318830-B2 | Photolatent catalysts based on organometallic compounds | BASF SE (DE) | 2012-11-27 | — | — | US | disclosed |
| US-8318830-B2 | Photolatent catalysts based on organometallic compounds | BASF SE (DE) | 2012-11-27 | — | — | US | disclosed |
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2010-09-16 | — | — | US | disclosed |
| EP-2203496-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (DE) | 2010-07-07 | — | — | EP | disclosed |
| WO-2009050115-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (CH) | 2009-04-23 | — | — | WO | disclosed |
| WO-2009050115-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | BASF SE (CH) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234485-A1 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS | PUF60, TST, MPST | ALDH1A1 1432/4885HPGD 1999/4885RAB9A 4001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.